Abstract
Purpose
The role of image-guided thermal ablation techniques for the nonoperative local management of painful osseous metastatic disease has expanded during recent years, and several advantages of cryoablation in this setting have emerged. The purpose of this study is to retrospectively evaluate and report a single-center experience of CT-guided percutaneous cryoablation in the setting of painful musculoskeletal metastatic disease.
Methods
This study was approved by the institutional review board and is compliant with the Health Insurance Portability and Accountability Act. Electronic medical records of all patients who underwent percutaneous image-guided palliative cryoablation at our institution were reviewed (n = 61). An intent-to-treat analysis was performed. Records were reviewed for demographic data and anatomical data, primary tumor type, procedure details, and outcome—including change in analgesic requirements (expressed as morphine equivalent dosages), pain scores (utilizing the clinically implemented visual analog scale), subsequent therapies (including radiation and/or surgery), and complications during the 24 h following the procedure and at 3 months. Patients were excluded (n = 7) if data were not retrospectively identifiable at the defined time points.
Results
Fifty-four tumors were ablated in 50 patients. There were statistically significant decreases in the median VAS score and narcotic usage at both 24 h and 3 months (p < 0.000). Six patients (11 %) incurred complications related to their therapy. Two patients had no relief at 24 h, of which both reported worsened pain at 3 months. One patient had initial relief but symptom recurrence at 3 months. Four patients went on to have radiation therapy of the ablation site at some point following the procedure.
Conclusions
CT-guided cryoablation is a safe, effective, reproducible procedural option for the nonoperative local treatment of painful musculoskeletal metastatic disease.
Similar content being viewed by others
References
Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res: Off J Am Assoc Cancer Res. 2006;15(12):6243–9.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol:Off J Eur Soc Med Oncol/ESMO. 2007;18(9):1437–49.
Jimenez Andrade JM, Mantyh P. Cancer Pain: From the Development of Mouse Models to Human Clinical Trials. In: Kruger L, Light AR, editors. Translational Pain Research: From Mouse to Man. Frontiers in Neuroscience. Boca Raton, FL2010.
Plunkett TA, Smith P, Rubens RD. Risk of complications from bone metastases in breast cancer. implications for management. Eur J Cancer. 2000;36(4)):476–82.
Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW. Bone cancer pain. Ann N Y Acad Sci. 2010;1198:173–81.
Goblirsch MJ, Zwolak PP, Clohisy DR. Biology of bone cancer pain. Clin Cancer Res:Off J Am Assoc Cancer Res. 2006;12(20 Pt 2):6231–5.
Soares LG, Chan VW. The rationale for a multimodal approach in the management of breakthrough cancer pain: a review. Am J Hosp Palliat Care. 2007;24(5):430–9.
Requarth J. Image-guided palliative care procedures. Surg Clin N Am. 2011;91(2):367–402.
McCullough HK, Bain RM, Clark HP, Requarth JA. The radiologist as a palliative care subspecialist: providing symptom relief when cure is not possible. AJR Am J Roentgenol. 2011;196(2):462–7.
Bhaskar AK. Interventional management of cancer pain. Curr Opin Support Palliat Care. 2012;6(1):1–9.
Nazario J, Tam AL. Ablation of bone metastases. Surg Oncol Clin N Am. 2011;20(2):355–68.
Nazario J, Hernandez J, Tam AL. Thermal ablation of painful bone metastases. Tech Vasc Interv Radiol. 2011;14(3):150–9.
Rosenthal D, Callstrom MR. Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology. 2012;262(3):765–80.
Goldberg SN, Charboneau JW, Dodd 3rd GD, Dupuy DE, Gervais DA, Gillams AR, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology. 2003;228(2):335–45.
Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Atwell TD, Farrell MA, et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skelet Radiol. 2006;35(1):1–15.
Munk PL, Rashid F, Heran MK, Papirny M, Liu DM, Malfair D, et al. Combined cementoplasty and radiofrequency ablation in the treatment of painful neoplastic lesions of bone. J Vasc Interv Radiol: JVIR. 2009;20(7):903–11.
Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116(4):989–97.
Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol:Off J Am Soc Clin Oncol. 2004;22(2):300–6.
Gangi A, Buy X. Percutaneous bone tumor management. Semin Interv Radiol. 2010;27(2):124–36.
Kurup AN, Callstrom MR. Image-guided percutaneous ablation of bone and soft tissue tumors. Semin Interv Radiol. 2010;27(3):276–84.
Prologo JD, Patel I, Buethe J, Bohnert N. Ablation zones and weight-bearing bones: points of caution for the palliative interventionalist. J Vasc Interv Radiol: JVIR. 2014;25(5):769–75.
Patel IJ, Pirasteh A, Passalacqua MA, Robbin MR, Hsu DP, Buethe J, et al. Palliative procedures for the interventional oncologist. AJR Am J Roentgenol. 2013;201(4):726–35.
Thacker PG, Callstrom MR, Curry TB, Mandrekar JN, Atwell TD, Goetz MP, et al. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients’ immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2011;197(2):510–5.
Popken F, Michael JW, Zarghooni K, Sobottke R, Kasper HU, Blaecker D, et al. Stability changes after cryosurgery in long tubular bones in correlation to histological results: an animal trial. Arch Orthop Trauma Surg. 2009;129(6):857–62.
Castaneda Rodriguez WR, Callstrom MR. Effective pain palliation and prevention of fracture for axial-loading skeletal metastases using combined cryoablation and cementoplasty. Tech Vasc Interv Radiol. 2011;14(3):160–9.
Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: Multicenter trial. Cancer. 2012 Oct 12
Masala S, Chiocchi M, Taglieri A, Bindi A, Nezzo M, De Vivo D, et al. Combined use of percutaneous cryoablation and vertebroplasty with 3D rotational angiograph in treatment of single vertebral metastasis: comparison with vertebroplasty. Neuroradiology. 2012 Sep 27
Kurup AN, Woodrum DA, Morris JM, Atwell TD, Schmit GD, Welch TJ, et al. Cryoablation of recurrent sacrococcygeal tumors. J Vasc Interv Radiol: JVIR. 2012;23(8):1070–5.
McMenomy BP, Kurup AN, Johnson GB, Carter RE, McWilliams RR, Markovic SN, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. Journal of vascular and interventional radiology:JVIR. 2012 Dec 19
Masala S, Schillaci O, Bartolucci AD, Calabria F, Mammucari M, Simonetti G. Metabolic and clinical assessment of efficacy of cryoablation therapy on skeletal masses by 18 F-FDG positron emission tomography/computed tomography (PET/CT) and visual analogue scale (VAS): initial experience. Skelet Radiol. 2011;40(2):159–65.
Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Patterson DE, et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007;243(1):276–83.
Truesdale CM, Soulen MC, Clark TW, Mondschein JI, Wehrenberg-Klee E, Malkowicz SB, et al. Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used. J Vasc Interv Radiol: JVIR. 2013;24(3):347–50.
Hallenbeck JL. Pain Management. In: Hallenbeck JL, editor. Palliative Care Perspectives. New York: Oxford University Press; 2003. p. 39–43.
Gordon DB, Stevenson KK, Griffie J, Muchka S, Rapp C, Ford-Roberts K. Opioid equianalgesic calculations. J Palliat Med. 1999;2(2):209–18.
Gainford MC, Dranitsaris G, Clemons M. Recent developments in bisphosphonates for patients with metastatic breast cancer. BMJ. 2005;330(7494):769–73.
Brady D, Parker CC, O’Sullivan JM. Bone-targeting radiopharmaceuticals including radium-223. Cancer J. 2013;19(1):71–8.
Mani A SC. Bone Metastases. In: Walsh, TD, editor. Walsh: Palliative Medicine. 1st ed. Philadelphia: Saunders; 2009.
Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65–76.
Wu JS, Wong R, Johnston M, Bezjak A, Whelan T. Cancer Care Ontario Practice Guidelines Initiative Supportive Care G. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594–605.
Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol: J Eur Soc Ther Radiol Oncol. 1997;45(2):109–16.
Agarawal JP, Swangsilpa T, van der Linden Y, Rades D, Jeremic B, Hoskin PJ. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol. 2006;18(10):747–60.
Ingunn HC, Robert E. Bone Metastases. Abeloff’s clinical oncology. 4th ed. Philadelphia: Churchill Livingstone/Elsevier; 2008. p. 845–71.
Fairchild A CE. Palliative Radiation Therapy. In: Walsh, TD, editor. Walsh: Palliative Medicine. 1st ed. Philadelphia: Saunders; 2009.
Wegener B, Schlemmer M, Stemmler J, Jansson V, Durr HR, Pietschmann MF. Analysis of orthopedic surgery of bone metastases in breast cancer patients. BMC Musculoskelet Disord. 2012;13(1):232.
Choi J, Raghavan M. Diagnostic imaging and image-guided therapy of skeletal metastases. Cancer Control: J Moffitt Cancer Cent. 2012;19(2):102–12.
Callstrom MR, Charboneau JW. Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol. 2007;10(2):120–31.
Kurup AN, Callstrom MR. Ablation of skeletal metastases: current status. J Vasc Interv Radiol: JVIR. 2010;21(8 Suppl):S242–50.
Ng KK, Lam CM, Poon RT, Shek TW, To JY, Wo YH, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol. 2004;11(7):650–7.
Blackwell TS, Debelak JP, Venkatakrishnan A, Schot DJ, Harley DH, Pinson CW, et al. Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery. 1999;126(3):518–26.
Chapman WC, Debelak JP, Wright Pinson C, Washington MK, Atkinson JB, Venkatakrishnan A, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg. 2000;231(5):752–61.
Gravante G, Sconocchia G, Ong SL, Dennison AR, Lloyd DM. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int: Off J Int Assoc Study Liver. 2009;29(1):18–24.
Yang Y, Wang C, Lu Y, Bai W, An L, Qu J, et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepato-Biliary-Pancreatic Sci. 2012;19(6):674–84.
Jansen MC, van Hillegersberg R, Schoots IG, Levi M, Beek JF, Crezee H, et al. Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. Surgery. 2010;147(5):686–95.
Soanes WA, Ablin RJ, Gonder MJ. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol. 1970;104(1):154–9.
Ravindranath MH, Wood TF, Soh D, Gonzales A, Muthugounder S, Perez C, et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM. Cryobiology. 2002;45(1):10–21.
Erinjeri JP, Thomas CT, Samoilia A, Fleisher M, Gonen M, Sofocleous CT, et al. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. Journal of vascular and interventional radiology: JVIR. 2013 Apr 9
Bang HJ, Littrup PJ, Currier BP, Goodrich DJ, Aoun HD, Klein LC, et al. Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol: JVIR. 2012;23(6):761–9.
Bang HJ, Littrup PJ, Goodrich DJ, Currier BP, Aoun HD, Heilbrun LK, et al. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol: JVIR. 2012;23(6):770–7.
Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg. 2007;205(2):342–56.
Theodorescu D. Cancer cryotherapy: evolution and biology. Rev Urol. 2004;6 Suppl 4:S9–S19.
Conflict of interest
The primary author of this manuscript has consulted on behalf of Galil in the past (2012).
Disclosure
Have provided paid consultation in the past for Galil Medical.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prologo, J.D., Passalacqua, M., Patel, I. et al. Image-guided cryoablation for the treatment of painful musculoskeletal metastatic disease: a single-center experience. Skeletal Radiol 43, 1551–1559 (2014). https://doi.org/10.1007/s00256-014-1939-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-014-1939-x